Search results :

Dexmedetomidine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: N05CM18

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5
Systolic hypertension 28% - 42% x x
Respiratory depression 37% 32% x x x
Hypotension postmarketing — 13% - 56% 12% - 30% x x x x x
Diastolic hypertension 12% - 15% x x
Hypertension postmarketing — 4% - 30% 18% - 24% x x x x x
Hypokalaemia 9% - 13.1% x x
Hypomagnesaemia 1% - 7% x x
Constipation 6% - 6.1% x x
Generalised oedema 2% - 6% x x
Hypoglycaemia postmarketing — 5% - 6% x x x x
Infarction common x
Withdrawal syndrome common x
Tachycardia postmarketing — 1% - 44.3% 4% - 17% x x x x x
Myocardial ischaemia common x
Bradycardia postmarketing — 0% - 42% 3% - 4% x x x x
Atrial fibrillation postmarketing, 4% - 7% 3% x x x x
Respiratory failure 3% - 5% x x
Atelectasis 3% - 6% 3% x
Nausea postmarketing — 3% - 11% 2% - 9% x x x x x
Vomiting postmarketing — 3% - 4% 5% - 6% x x x x x
Dry mouth common, 1% - 4% 1% x x x x
Body temperature increased postmarketing — 0% - 7% 3% - 4% x x x x x
Anaemia postmarketing, 2% - 3% 2% x x x x
Hyperglycaemia common, 1.64% - 7% 2% x x x
Pleural effusion 2% - 6% 1% x x x
Chills 2% 3% x
Agitation postmarketing — 1% - 7% 3% x x x x x
Respiratory rate decreased 2% 4% x x
Hypoxia 2% - 4% 2% - 4% x x x x
Post procedural haemorrhage 2% - 4% 3% x
Hypovolaemia postmarketing, 3% - 5% 2% x x x x
Renal failure acute 1% - 2% x x
Acute respiratory distress syndrome 1% - 2% x x
Acidosis postmarketing, 1% - 2% 1% - 2% x x x x
Hypocalcaemia 1% - 2% 0% x
Oliguria postmarketing, 1% - 2% 0% - 1% x x x x
Pulmonary oedema 1% - 3% 1% x x
Sinus tachycardia 1% - 2% 1% x
Wheezing 1% - 2% 0% x
Abdominal distension uncommon x x
Cardiac output decreased uncommon x
Atrioventricular block first degree uncommon x
Metabolic acidosis uncommon x
Hypoalbuminaemia uncommon x
Drug ineffective uncommon x
Oedema peripheral 0% - 2% 1% x x
Ventricular tachycardia postmarketing, 1% - 5% 1% x x x x
Abdominal pain postmarketing x x x x
Respiratory acidosis postmarketing x x x x
Apnoea postmarketing x x x x
Arrhythmia postmarketing x x x x
Atrioventricular block postmarketing x x x x
Mental disorder postmarketing x x x x x
Bronchospasm postmarketing x x x x
Cardiovascular disorder postmarketing x x x
Confusional state postmarketing x x x x
Delirium postmarketing x x x x
Diarrhoea postmarketing x x x x
Dizziness postmarketing x x x x
Dyspnoea postmarketing, uncommon x x x x x
Hallucination postmarketing, uncommon x x x x x
Headache postmarketing x x x x
Cardiac arrest postmarketing x x x x x
Block heart postmarketing x x x x
Cardiac disorder postmarketing x x x x x
Haemorrhage postmarketing, 3% 4% x x x
Hyperbilirubinaemia postmarketing x x x
Hypercapnia postmarketing x x x x
Hyperkalaemia postmarketing x x x x
Illusion postmarketing x x x x
Nephropathy postmarketing x x x
Myocardial infarction postmarketing x x x
Neuralgia postmarketing x x x x
Neuritis postmarketing x x x x
Pain postmarketing, 2% 2% x x x x
Neuropathy peripheral postmarketing x x x
Convulsion postmarketing x x x
Speech disorder postmarketing x x x x
Supraventricular tachycardia postmarketing x x x x
Thirst postmarketing — 2% 1% x x x x x
Angiopathy postmarketing x x x x
Disorder sight postmarketing x x x x
Ventricular arrhythmia postmarketing x x x x
Photopsia postmarketing x x x x
Hepatic function abnormal postmarketing x x
Blood urea increased postmarketing x x
Phosphatase alkaline increased postmarketing x x x x
Malnutrition postmarketing x x x x x
Red blood cell disorders postmarketing x x x
Pulmonary congestion postmarketing x x x
Extrasystoles postmarketing x x x x
Hyperpyrexia postmarketing, 2% 3% x x x x
Rigors postmarketing, 2% 3% x x x x
Light anaesthesia postmarketing x x x
Electrocardiogram T wave inversion postmarketing x x x x
Blood pressure fluctuation postmarketing x x x x
Sweating increased postmarketing x x x x
Hypoventilation postmarketing x x x x
Abnormal vision postmarketing x x x x
Anxiety x x
Infection x
Decubitus ulcer x
Rash x
Gastrointestinal disorder x x
Hypernatraemia x
Body temperature decreased x
Leukocytosis x
Mediastinal disorder x
Pneumonia x
Pregnancy x
Septic shock x
Thrombocytopenia x
Urinary tract infection x
Hypophosphataemia x
Gamma-glutamyltransferase increased x
Aspartate aminotransferase increased x
Alanine aminotransferase increased x
Haemoglobin decreased x
Hypertension worsened x
Sepsis x
Electrolyte imbalance x
Sinus arrest x x x
Fluid overload x
Urea increased x
Pharyngolaryngeal pain x
Somnolence x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

DEXMEDETOMIDINE

Side effects:72
Source:FDA Structured Product Label

DEXMEDETOMIDINE

Side effects:92
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label